Home   >  
Angiogenesis/Protein Tyrosine Kinase
  • MAPK Pathway
∨
  >  
PDGFR
  • VEGFR
  • c Kit
  • FLT3
  • Raf
∨
  >   Sorafenib
Sorafenib Chemical Structure

Sorafenib

Data Sheet For research use only. Not for human use.
Cat. No. ：BCP01767CAS No. ：284461-73-0Purity：98%
chem_1Get Quotation Now
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

  

* Applicant name

Catalog Number

  

* Institution/Company

* Email address

  

Phone number

Country

  

* Quantity Required

Remarks
Submit
Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

  

* Applicant name

Catalog Number

  

* Institution/Company

* Email address

  

Phone number

Country

  

* Quantity Required

Remarks
Submit
Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

  

* Applicant name

Catalog Number

  

* Institution/Company

* Email address

  

Phone number

Country

  

* Quantity Required

Remarks
Submit
  • Publications Citing of Biochempartner's Sorafenib
Int J Nanomedicine. 2015; 10: 6185–6198. Oncotarget. 2016 Jun 14; 7(24): 36767–36782.
Int J Nanomedicine. 2016; 11: 2329–2343. Nanomicro Lett. 2021 Dec; 13: 6.
Nanomicro Lett. 2021 Dec; 13: 6. Cell Death Dis. 2017 May; 8(5): e2766.
  • Chemical Properties&Biological Activity
CAS No. 284461-73-0 Cat. No. BCP01767
Name Sorafenib
Synonyms BAY 439006; BAY439006; BAY-439006;BAY 43-9006;
SMILES O=C(NC(C=C1)=CC=C1OC2=CC(C(NC)=O)=NC=C2)NC3=CC=C(Cl)C(C(F)(F)F)=C3
Chemical Name
Formula C21H16ClF3N4O3 M. Wt 464.83
Purity 98% Storage Store at 4-8°C
Description Sorafenib is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation; in addition, sorafenib inhibits the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Sorafenib was approved in 2005 for use in the treatment of advanced renal cancer.
  • Quality Control&Technical Support
H-NMR HPLC
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Sorafenib supplier,Sorafenib purchase,Sorafenib manufacturer,Sorafenib distributor,Sorafenib cost,Sorafenib buy,Sorafenib for sale

0086-13720134139